SA biotech pursuing deal to access $5B China market

FEBRUARY 8, 2021 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San-Antonio Business Journal “China represents a $5 billion market for CyPath© Lung. An estimated 780,000 people will be diagnosed annually in China with lung...

Understanding Cancer’s Home

JANUARY 19, 2021 Contributed Commentary by Maria Zannes When it comes to cancer, there are many tools for cancer diagnosis, from initial screenings to invasive biopsies. The one selected depends on a number of factors, not the least of which is how the patient...

Stop and Screen

NOVEMBER 23, 2020 By: Maria Zannes, HealthcareNOW Radio My father was 39 when he died of lung cancer, attributed to his twenty-year Lucky Strikes habit. The U.S. Surgeon General had yet to issue his first report on the health hazards of smoking in 1960 when my father...

SA Biotech Nearing Launch of Breakthrough Cancer Test

AUGUST 11, 2020 As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal A local pathology practice has initiated a validation study of San Antonio-based bioAffinity Technologies’ CyPath Lung early...

Dr. Lydia Bederka to present at CYTO2020

Dr. Lydia Bederka will present the poster “Sputum-Derived Cellular Profiles Produced by Flow Cytometric Analysis” (Poster #P223) at the International Society for the Advancement of Cytometry conference, CYTO2020 on August 4-5, 2020. Cytometry is the quantitative...

SA has More Room for Women in Bioscience C-suite

AUGUST 29, 2019 As published in the San Antonio Business Journal By W. Scott Bailey  – Senior Reporter, San Antonio Business Journal While there is acknowledgment that women have made progress in their climb to executive-level positions in San Antonio’s...

Advancing Early Lung Cancer Detection Symposium

bioAffinity Technologies proudly will present at Advancing Early Lung Cancer Detection at the Cleveland Clinic, an invitation-only symposium that brings together clinical experts, advocacy groups and industry leaders working to advance new technologies and methods...

Rising SA biotech on threshold of national product launch

OCTOBER 10, 2018 As published in the San Antonio Business Journal By W. Scott Bailey  – Senior Reporter, San Antonio Business Journal BioAffinity Technologies, a San Antonio-based biotech, has struck a deal with another local company, Precision Pathology Services, to...

bioAffinity Technologies adds talent in march to market

DECEMBER 8, 2017 As published in the San Antonio Business Journal By W. Scott Bailey In an effort to shore up plans to commercialize its initial product, bioAffinity Technologies is adding more scientific and financial firepower to its arsenal. The San Antonio-based...

City of San Antonio Invests in bioAffinity Technologies

MARCH 9, 2017 (SAN ANTONIO, TX) The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity Technologies, a biotech company focused on the significant unmet need for non-invasive, early-...

bioAffinity Technologies Update

FEBRUARY 1, 2016 @8:00 am- 5:00 pm Maria Zannes, President & Chief Executive Officer February 2016 Quarterly Luncheon of the Texas Research & Technology Foundation in San Antonio Omni Hotel San Antonio, TX United States Texas Research & Technology...